The Insight by Oaktree Capital cover image

Conversations: Walking into the Unknown with Howard Marks, David Rosenberg, and Aman Kumar

The Insight by Oaktree Capital

00:00

Shifts in Life Sciences Public Equity Market

This chapter discusses the significant shifts in the life sciences public equity market over the past few years, including volatile valuations during the pandemic and the decline in biotech valuations since February 2021. It identifies the reasons behind this weakness and highlights the increase in non-dilutive financing opportunities in the sector.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app